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Abstract
Background: Childhood cancer differs from most common adult cancers, suggesting a distinct aetiology for some
types of childhood cancer. Our objective in this study was to test the difference in incidence rates of 4 non-CNS
embryonic tumours and their correlation with socioeconomic status (SES) in Brazil.
Methods: Data was obtained from 13 Brazilian population-based cancer registries (PBCRs) of neuroblastoma (NB),
Wilms’tumour (WT), retinoblastoma (RB), and hepatoblastoma (HB). Incidence rates by tumour type, age, and
gender were calculated per one million children. Correlations between social exclusion index (SEI) as an indicator
of socioeconomic status (SES) and incidence rates was investigated using the Spearman’s test.
Results: WT, RB, and HB presented with the highest age-adjusted incidence rates (AAIRs) in 1 to 4 year old of both
genders, whereas NB presented the highest AAIR in ≤11 month-olds. However, differences in the incidence rates
among PBCRs were observed. Higher incidence rates were found for WT and RB, whereas lower incidence rates
were observed for NB. Higher SEI was correlated with higher incidences of NB (0.731; p = 0.0117), whereas no SEI
correlation was observed between incidence rates for WT, RB, and HB. In two Brazilian cities, the incidence rates of
NB and RB were directly correlated with SEI; NB had the highest incidence rates (14.2, 95% CI, 8.6-19.7), and RB the
lowest (3.5, 95% CI, 0.7-6.3) in Curitiba (SEI, 0.730). In Natal (SEI, 0.595), we observed just the opposite; the highest
incidence rate was for RB and the lowest was for NB (4.6, 95% CI, 0.1-9.1).
Conclusion: Regional variations of SES and the incidence of embryonal tumours were observed, particularly
incidence rates for NB and RB. Further studies are necessary to investigate risk factors for embryonic tumours in
Brazil.
Background
Childhood cancer differs from most common adult can-
cers, suggesting a distinct aetiology for some types of
childhood cancer. Embryonic tumours that afflict very
young children probably originate from immature tissue,
and their microscopic morphological appearance resem-
bles tissues in the developing embryo and foetus. Defects
in tissue growth pathways and in their differentiation
during the prenatal/postnatal period would promote
tumour genesis [1,2].
Age standardized incidence rates for neuroblastoma
(NB), Wilms’ tumour (WT), retinoblastoma (RB), and
hepatoblastoma (HB) vary worldwide from 7-12, 4-10,
3-5, and 0.8-1 per million children less than 15 years of
age, respectively [3]. Lower incidence rates of NB were
observed in southern and eastern Asia and were extre-
mely rare in African countries, but had higher incidence
rates in Western European countries, the United States,
Australia, and New Zealand [4]. Regarding WT, higher
incidence rates were observed in Sweden, Afro-Americans,
and in São Paulo, Brazil [3]. In developing countries, the
incidence rates of RB are generally higher and seem to be
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associated with non-inheritable forms of the disease.
These variations in incidence, which may be related to
possible risk factors and geographical and ethnic patterns,
provide clues to aetiological factors. Additionally, socioe-
conomic status (SES) might have implications and/or asso-
ciations with the different incidence rates [3-5]. Residential
area and parental educational attainment level were used
as indicators of SES, and the risk of childhood cancers was
tested mostly in acute leukaemia, but few studies also ana-
lyzed embryonal tumours [6-8]. Although some evidence
exists for an association, it is not conclusive. The possible
association between SES and childhood cancer risk have
raised the hypothesis that potential aetiological factors
could be linked with modern lifestyles.
There are a lack of studies regarding the regional dif-
ferences in the incidence of embryonic tumours such as
WT, RB and NB; consequently, there are very limited
data on causes and pathologic mechanistic pathways. RB
has a genetic aetiology due to somatic or germinal RB1
gene mutations [9]. The International Agency for
Research on Cancer (IARC) has promoted multicenter
studies to uncover the occurrence of childhood cancer
to provide etiological clues. In the first descriptive analy-
sis of the incidence of childhood cancer in Brazil, higher
age-specific incidence rates of RB were observed in
some areas of the country [10]. Our objective in the
study was to test whether SES correlated with the inci-
dence rates of WT, RB, NB and HB as the main non-
central nervous system embryonic tumours. The social
exclusion index (SEI) was used because it is a synthesis
of all variables related to poverty and inequalities. This
index was constructed based on suitable life conditions,
literacy, and youth vulnerability similar to that applied
for the Human Development Index [11,12].
Methods
Dataset
Data analysed were extracted from the databases of
PBCRs located in major Brazilian cities as described pre-
viously [10]. For this analysis, 13 of 14 PBCRs were
selected; one PBCR (Jaú) was excluded because no
embryonic tumours were registered. Children’s age
ranges were placed into four groups as follows: younger
than 12 months of age, ≥1 to 4 years of age; 5 to 9 years
of age; and 10 to ≤14 years of age. The International
Classification of Childhood Cancer was used and only
the following tumours were selected: NB and ganglio-
neuroblastoma (from Group IV the subgroup IVa), RB
(Group V), WT (from Group VI- the subgroup VI.a),
and HB (from Group VII the subgroup VIIa) [13]. The
cumulative records of RB cases from the PBCR database
did not classify RB as bilateral and unilateral. Ethical
approval was waived for the kind of study.
Social exclusion index
The description of the SEI construction is described in
detail elsewhere [11]. Briefly, the first dimension
includes a poverty indicator, an employment indicator,
and an inequality indicator; the second dimension com-
prises 2 indicators of literacy and parental years of
study; and the last dimension includes a youth and a
regional violence indicator. Cities were classified by the
social exclusion index (SEI), which ranges from 0 (mini-
mum) to 1 (maximum) with a higher SEI score indicat-
ing better socio-economic status.
Statistical methods
Age-adjusted incidence rates (AAIR) were estimated
with the direct method using the world population pro-
posed for age groups younger than 15 years [14]. The
incidence rate per 1,000,000 inhabitants refers to the
risk of new cases. For all 13 PBCRs included, analyses
included the number of new cases, the absolute and
relative values, and AAIR according to tumour type,
gender, and age range.
Correlations between SEI and incidence rates were
investigated using Spearman’s test. The 95% confidence
intervals (CI) were calculated using the Poisson approxi-
mation, or exactly when less than 30 cases were
observed.
Results
AAIR for each of the selected embryonic tumours are
shown in Table 1. The median AAIR of NB in both
sexes was 5.9 per million, and was lower in Manaus
(2.3, 95% CI, 0.0-4.6) and higher in Curitiba (14.2, 95%
CI, 8.6-19.7). The median AAIR of WT was 9.5 per mil-
lion, and was lower in Natal (5.2, 95% CI, 0.0-10.3) and
higher in Goiania (18.0, 95% CI, 10.6-25.4). The median
AAIR of RB was 6.6 per million, and was lower in Curi-
tiba (3.5, 95% CI, 0.7-6.3) and higher in Natal (12.7, 95%
CI, 4.3-21.0). The median AAIR of HB varied from 0.0
to 2.8 per million as shown in Table 1.
The age specific incidence rates (ASIR) are shown in
Table 2. The higher ASIR of NB was seen in children
≤11 months of age in the majority of the PBCR, whereas
in two regions (Curitiba and Distrito Federal) a higher
ASIR for NB was found in children ≥1 to 4 years of age.
WT had the highest ASIR in children between the ages
of ≥1 to 4 years with a median of 18.7 cases per million.
RB had the highest ASIR in children between the ages
of ≥1 to 4 years with a median of 15.6 cases per million.
The ratio distribution of the 4 selected embryonic
tumours is shown in Figure 1. The most common
tumour in 10 PBTRs in the percentage distribution was
WT (38-60%), whereas NB was the most common
in only two PBCRs in the percentage distribution;
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São Paulo (34%) and Curitiba (61%). RB was the most
common embryonic tumour in Natal (53%).
The SEI varied from 0.522 to 0.761. The lowest SEI
was observed in the city of Manaus located in the north
(0.522) and the highest SEI was observed in Porto Ale-
gre (0.761) in southern Brazil. The correlation between
SEI and the incidence rates for the 3 embryonic
tumours (NB, RB, WT) are shown in Figure 2. Overall,
the correlation between SEI and WT (p = 0.4865), RB
(p = 0.6496), and HB (p = 0.5843) were not statistically
significant (Spearman’s rank correlation test), but the
incidence rate of NB was significantly correlated with SEI
(0.731; p = 0.0117). The differences in the incidence rates
of NB and RB correlating with SEI were observed in Cur-
itiba and Natal. In Curitiba (SEI, 0.730), a high AAIR of
NB and the lowest AAIR of RB was observed, whereas
the opposite was observed in Natal (SEI, 0.595) with a
high AAIR of RB and one of the lowest AAIR of NB.
Table 1 Age adjusted incidence rate (AAIR) per million for embryonal tumours in 13 Brazilian PBCR
PBCR AAIR* (0 to 14 years)
NB 95% CI RB 95% CI WT 95% CI HB 95% CI
Aracaju (1996-2000) 5.90 (-0.78;12.58) 6.99 (0.09;13.90) 10.93 (2.13;19.72) 1.97 (-3.45;7.39)
Campinas (1991-1995) 5.63 (11.11;10.16) 7.58 (2.31;12.85) 9.53 (3.61;15.45) 1.52 (-1.43;4.46)
Curitiba (1998 - 2002) 14.18 (8.60;19.75) 3.52 (0.70;6.34) 5.76 (2.19;9.34) 0.00 -
Distrito Federal (1999-2002) 7.13 (3.63;10.64) 3.80 (1.17;6.44) 10.47 (6.18;14.77) 0.48 (-0.83;1.78)
Fortaleza (1998-2002) 2.40 (0.61;4.19) 3.55 (1.35;5.76) 6.37 (3.42;9.32) 0.00 -
João Pessoa (2000-2004) 3.54 (-0.52;7.60) 4.32 (-0.57;9.20) 12.37 (4.26;20.49) 0.00 -
Manaus (1999-2002) 2.33 (0.05;4.61) 5.83 (2.22;9.44) 6.29 (2.57;10.01) 1.59 (-0.96;4.14)
Natal (1998-2001) 4.60 (0.08;9.12) 12.67 (4.33;21.02) 5.18 (0.03;10.33) 0.00 -
Porto Alegre (1998-2002) 11.82 (6.16;17.48) 7.54 (2.87;12.21) 13.56 (7.43;19.69) 2.78 (-1.08;6.64)
Recife (1997-2001) 11.18 (5.98;16.38) 4.98 (1.51;8.45) 13.48 (7.92;19.04) 0.43 (-0.75;1.60)
Salvador (1998-2002) 4.91 (2.24;7.57) 6.59 (3.54;9.65) 9.48 (5.83;13.13) 2.13 (-0.27;4.53)
Goiânia (1999-2003) 11.51 (5.65;17.37) 8.34 (3.17;13.51) 18.03 (10.63;25.44) 0.00 -
São Paulo (1998-2002) 9.60 (7.80;11.41) 9.08 (7.32;10.85) 8.52 (6.84;10.19) 0.80 (0.07;1.54)
Median 5.90 6.59 9.48 0.43
* per million.
Abbreviations: NB. Neuroblastoma; RB. Retinoblastoma; WT. Wilms’ tumors; HB. Hepatoblastoma.
Source: PBCR: Population-Based Cancer Registries; MP/Fundação Instituto Brasileiro de Geografia e Estatística (IBGE); MS/INCA/CONPREV/Information Division. 2008
(http://www.inca.gov.br).
Table 2 Age-standardized incidence rate (ASIR) per million for embryonal tumours in 13 Brazilian PBCR
ASIR
PBCR 0 to 11 months 1 to 4 years 5 to 9 years 10 to 14 years
NB RB WT HB NB RB WT HB NB RB WT HB NB RB WT HB
Aracaju (1996-2000) 25.01 0.00 0.00 25.01 12.76 12.76 25.51 0.00 0.00 9.48 9.48 0.00 0.00 0.00 0.00 0.00
Campinas (1991-1995) 26.30 26.30 39.45 0.00 9.34 15.57 18.69 0.00 2.35 2.35 2.35 0.00 0.00 0.00 0.00 0.00
Curitiba (1998 - 2002) 15.28 7.64 7.64 0.00 35.98 9.47 15.15 0.00 4.44 0.00 1.48 0.00 1.40 0.00 0.00 0.00
Distrito Federal (1999-2002) 5.99 0.00 5.99 0.00 12.36 12.36 24.72 1.55 7.72 0.00 5.15 0.00 1.26 0.00 2.51 0.00
Fortaleza (1998-2002) 0.00 9.65 4.82 0.00 5.91 7.10 15.38 0.00 0.95 1.89 3.79 0.00 0.89 0.00 0.00 0.00
João Pessoa (2000-2004) 0.00 0.00 18.65 0.00 4.64 13.92 27.85 0.00 3.57 0.00 7.14 0.00 3.26 0.00 0.00 0.00
Manaus (1999-2002) 7.38 7.38 0.00 0.00 5.67 17.01 17.01 1.89 0.00 0.00 3.25 1.66 0.00 0.00 0.00 1.66
Natal (1998-2001) 0.00 38.77 19.38 0.00 0.00 24.17 4.83 0.00 11.21 3.74 3.74 0.00 3.38 3.38 3.38 0.00
Porto Alegre (1998-2002) 19.07 9.53 9.53 9.53 22.02 22.02 31.80 4.89 7.72 0.00 7.72 1.79 3.58 0.00 1.79 1.79
Recife (1997-2001) 25.96 17.31 0.00 0.00 23.26 8.46 25.38 0.00 4.80 3.20 16.00 1.47 1.47 0.00 1.47 1.47
Salvador (1998-2002) 24.74 9.89 4.95 4.95 9.72 15.79 24.29 3.64 0.00 2.89 4.82 0.00 0.00 0.00 0.00 0.00
Goiânia (1999-2003) 21.74 32.61 43.47 0.00 18.82 18.82 32.26 0.00 10.63 0.00 12.76 0.00 1.96 0.00 1.96 0.00
São Paulo (1998-2002) 22.14 24.47 10.49 3.50 20.26 20.85 16.45 1.47 3.81 1.67 6.91 0.00 1.32 0.66 1.32 0.00
Median 15.28 9.53 5.99 0.00 12.36 15.57 18.69 0.00 3.81 0.00 4.82 0.00 1.32 0.00 0.00 0.00
Abbreviations: NB. Neuroblastoma; RB. Retinoblastoma; WT. Wilms’ tumours; HB. Hepatoblastoma; Source: Population-Based Cancer MP/Fundação Instituto
Brasileiro de Geografia e Estatística (IBGE); MS/INCA/CONPREV/Information Division. 2008 (www.inca.gov.br).
de Camargo et al. BMC Cancer 2011, 11:160
http://www.biomedcentral.com/1471-2407/11/160
Page 3 of 6
Discussion
Incidence rates, age, and gender distributions provide
insights into tumour initiation and aetiology. This is the
first report that explores the geographic variations in
the incidence of select embryonic tumours and differ-
ences in SES in an emerging middle-income country
like Brazil.
NB has the fourth highest incidence rate in children
less than 14 years of age in developed countries [15,16].
In a recent analysis of the Surveillance, Epidemiology,
and End Results database, the incidence of NB seems to
be increasing in nonmetropolitan counties of the United
States [17]. A very low incidence rate was observed in
Mexico, even in children under one year of age [18,19].
Historically, the incidence rates of NB are generally
higher in regions with a higher standard of living [20].
In 13 Brazilian PBCRs, the NB incidence rates varied
from 2.3 to 14.2 per million. The higher incidence cor-
related with Brazilian cities with high SEIs. Additionally,
we observed that the higher incidence rates occurred in
children between the ages of 1 to 4 years living in cities
with high SEIs (Curitiba, DF and Porto Alegre). These
data might corroborate the previous speculation related
to the timing of the diagnosis [21]. The biology of NB
cases includes spontaneous regression in children less
than one year of age. The ASIR differences observed in
the cities independently of the SEI ruled out that under-
diagnosis or under-ascertainment of NB cases as the
reasons for distinct incidence rates in Brazilian regions.
Etiological studies have explored the environmental and
genetic predisposition of NB [22].
WT incidence rates world-wide are lower (4 to 10
cases per million) than those of NB according to data
reported by IARC [4]. The rate of WT is higher in
females than males and no significant changes in inci-
dence rates were reported. In São Paulo, the WT inci-
dence rates have remained stable (8.5 per million) since
the 1990s [3,4]. Presently, we observed higher incidence
Figure 1 Percentage distribution of NB, WT, RB, HB, expressed as the total cases of all 4 embryonal tumours.
Figure 2 Correlation between the SEI and AAIR for 3
embryonal tumours (NB, WT, RB).
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rates in 8 PBCR, which vary from 9.5 per million in Sal-
vador to 18 per million children in Goiania. WT was
the most common embryonic tumour in 10 of the 13
PBCRs analysed. Higher incidences rates were observed
in children between 1 and 4 years of age. SEI was not
related to the incidence rates of WT. For instance, high
WT incidence rates were observed in Porto Alegre (SEI,
0.761) and João Pessoa (SEI, 0.559), whereas low inci-
dence rates were found in Natal (SEI, 0.595) and Curi-
tiba (SEI, 0.730). The potential involvement of genetic
and environment exposures in the development of WT
is challenge to be explored, because in WT both genetic
and environmental component are involved, although
the exact aetiology remains unclear [23,24]. In a small
case-control study conducted in different Brazilian cities,
positive associations among parental exposure to pesti-
cides before birth and maternal exposure to dipyrone
during pregnancy were observed [25,26]. An elegant
ecological analysis described by McNally et al suggested
that environmental exposure and life style are associated
with WT and soft tissue sarcomas [27]. Recently, a
study from Ontario demonstrated a 30% decline in the
incidence of WT after the folic acid flour fortification
initiative [28].
Higher RB incidence rates were reported for other
developing areas such as Malawi, Africa, and Colombia
[4]. In Europe, North America, and Australia, RB corre-
sponds to 2-4% of all tumours in infancy [29]. Data from
the Automated Childhood Cancer Information System
project showed that incidence rates were higher in north-
ern Europe [30]. We observed a very high incidence rate
of RB in Brazil, with more than 15 cases per million
(0-4 years) similar to Mexico [10,19,31]. The higher RB
incidence rate could correlate with deprivation. However,
overall in the PBCRs, a significant correlation between
the SEI of the location and RB incidence rates was not
observed. Therefore, in Natal (SEI, 0.595), the RB inci-
dence rates were high, whereas the RB incidence rate was
the lowest in Curitiba (0.73). Clinically, RB occurs in two
forms; a unilateral form that corresponds to 90% of non-
inheritable (sporadic) RB, and a bilateral form that is
inheritable or germinal, exemplifying the classical cases
of a cancer with an inheritable genetic anomaly of
tumour suppressor gene RB1 [5,32]. Detection of onco-
genic papillomavirus (HPV) was described in different
countries including Mexico and India [33,34]. Recently,
two Brazilian studies investigating the presence HPV in
paraffin-embedded tumour specimens demonstrated
results ranging from 4.6% to 28%. Cases were ascertained
in São Paulo and Campinas, both cities with referral cen-
ters for RB treatment [35,36].
Hepatoblastoma is the rarest embryonic tumour
affecting children younger than the age of 5 years. The
age-standardised incidence in European and America
countries are 1.2 per million. There appears to be very
little geographic variation world-wide, and the incidence
rate is approximately 1 case per million children [23,37].
Because there are very few cases and they occurred in
only 8 PBCR, caution should be used when interpreting
the variation in the incidence of hepatoblastoma in
Brazil.
Conclusion
A limitation of the present study is that, firstly, underre-
ported cases as well as misdiagnoses might occur in
some areas. Other important limitations could be caused
by the SES not being individually measured. Our study
demonstrates distinct differences in incidence rates of
embryonic tumours between Brazilian regions that are
useful for prioritizing further research in terms of socio-
economic status and geographic variations.
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